Title
Authorize the Chief Executive Officer for Natividad Medical Center (NMC) or a designee to execute amendment No. 4 to the agreement (A-14125) with Monarch Medical Technologies, LLC for glucose management system enterprise software subscription services, extending the agreement an additional three (3) period (February 1, 2026 through January 31, 2029) for a revised full agreement term of October 1, 2018 through January 31, 2029 and adding $185,736 for a revised total agreement amount not to exceed $645,559.
Report
RECOMMENDATION:
It is recommended the Board of Supervisors:
Authorize the Chief Executive Officer for Natividad Medical Center (NMC) or a designee to execute amendment No. 4 to the agreement (A-14125) with Monarch Medical Technologies, LLC for glucose management system enterprise software subscription services, extending the agreement an additional three (3) period (February 1, 2026 through January 31, 2029) for a revised full agreement term of October 1, 2018 through January 31, 2029 and adding $185,736 for a revised total agreement amount not to exceed $645,559.
SUMMARY:
EndoTool is a clinical decision support software that provides personalized recommendations for insulin therapy to better control the patient’s glycemic rates in a more automated fashion. Instead of the provider choosing from multiple order sets, it gives the provider the ability to order EndoTool management and the nurse follows the instructions from EndoTool rather than hand calculating insulin dosage. The software was built using Natividad Medical Center’s policies, procedures and protocols that define insulin management and glycemic control. The system is HIPAA compliant and integrates with Meditech.
DISCUSSION:
EndoTool has enhanced Natividad Medical Center’s glycemic management by reducing the time to achieve glucose control, minimizing hyper - hypoglycemic events, and improving overall patient outcomes. Beyond clinical benefits, EndoTool contributes to oper...
Click here for full text